SAN DIEGO, July 19, 2022 (GLOBE NEWSWIRE) — Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to announce its second quarter 2022 financial and operating results after the market closes on Thursday, August 4, 2022, and will host a conference call and webcast on the same day at 2:00 p.m. PT/ 5:00 p.m. ET.
To participate in the conference call by telephone, dial (877) 407-0890 or (201) 389-0918 and reference Maravai LifeSciences. The call will also be available via live or archived webcast on the “Investors” section of the Maravai web site at https://investors.maravai.com.
About Maravai
Maravai is a leading life sciences company providing critical products to enable the development of drug therapies, diagnostics, and novel vaccines and to support research on human diseases. Maravai’s companies are leaders in providing products and services in the fields of nucleic acid synthesis and biologics safety testing to many of the world’s leading biopharmaceutical, vaccine, diagnostics, and cell and gene therapy companies.
CONTACT: Contact Information: Media Contact: Sara Michelmore MacDougall Advisors +1 781-235-3060 maravai@macdougall.bio Investor Contact: Deb Hart Maravai LifeSciences + 1 858-988-5917 ir@maravai.com
Lenses feature novel hydrogel material with patented controlled-release technology Only lenses available in the world…
WHITE PLAINS, N.Y.--(BUSINESS WIRE)--Spectrum Vascular (“Spectrum” or the “Company”), a provider of vascular access and…
Winter Park, Florida--(Newsfile Corp. - April 14, 2025) - Adia Nutrition Inc. (OTC Pink: ADIA),…
Treatment of Major DSM-5 Disorders, Including Addiction, Depression and Anxiety, With Sub-Hallucinogenic Mescaline DosesExtraction Technology…
Research to explore Promino's patented amino acid blend in addressing treatment-related muscle wasting in two…
26 USOSM Surgeon Partners to Participate Across Seven States IRVING, Texas, April 14, 2025 (GLOBE…